Timolol maleate gel (Auson Pharmaceuticals)

马来酸噻吗洛尔凝胶 (奥全生物医药)

Report date: 2026/05/13 20:02:10

Base Information

Drug NameTimolol maleate gel (Auson Pharmaceuticals)
Drug Alias NameASN-001ASN001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors antagonists
TargetsBeta adrenergic receptors
Therapy Area/IndicationsGlaucoma, Open-AngleOcular HypertensionHemangioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShanghai Auson Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Auson Pharmaceuticals Co LtdAuson Pharmaceuticals IncShanghai New Asiatic Medicine Industry Minhang Co Ltd
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleOcular HypertensionHemangioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A